Cerus Endovascular today said it received CE mark approval for its 021 Contour Neurovascular System.
The system is compatible with smaller commercially available 021 microcatheters to treat saccular intracranial aneurysms. It features a fine mesh braid that is deployed across the next of the aneurysm sac for flow diversion and flow disruption in a single implant.
“IN response to numerous requests from the clinical community and physicians we work closely with, we continue to aggressively expand our product portfolio to offer an even more comprehensive suite of products to meet market needs, complementing our Contour 027 device and Neqstent platform, which recently received CE mark approval,” present Stephen Griffin said in a news release.
The company said the new, lower profile system will allow physicians to access more distally challenging vascular anatomies.
“The latest approval testifies to the strength of our product pipeline and represents another critical step in our go-to-market strategy via a controlled roll-out,” chairman Sam Milstein said. “We look forward to initiating sales later this year and are pleased to be able to offer the medical community additional key solutions that will meaningfully benefit patient care.”